1. Targets to retard the progression of diabetic nephropathy
Mark E. Cooper, Karin Jandeleit-Dahm, Merlin C. Thomas 
Kidney International 
Volume 68, Issue 4, Pages (October 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1
Glomerular hypertrophy and mesangial expansion in diabetic c57 and diabetic apolipoprotein E knockout mice. (A) c57. (B) Diabetic c57. (C) Apolipoprotein E knockout control. (D) Diabetic apolipoprotein E knockout [periodic acid-Schiff (PAS) staining ×400].
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
The prevalence of functional erythropoietin (EPO) deficiency (<31 IU/mL) and reduced iron availability [transferrin saturation (TSAT) <16%] in patients with type 2 diabetes and anemia, stratified according to the renal function. GFR is glomerular filtration rate.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions